Refine by
Interventional Cardiologist Suppliers Serving Uruguay
13 companies found
based inWeidingen (Wiltz), LUXEMBOURG
Since 2020, IMA-X s.a. is the exclusive distributor of Lemer Pax in the Benelux. We offer you complete solutions, which cover all the needs of a nuclear medicine department. Discover our assortment for low, medium and high energy. X-ray protection ...
based inOrvault, FRANCE
ATA was born in 1987 in Nantes, in France, and quickly became an expert in air handling units for various sectors: data centers, telecommunications, food industry, pharmaceuticals, etc. Few years later, ATA started to provide air treatment solutions ...
The continued development of both minimally invasive procedures and imaging technologies led to the development of the hybrid operating ...
based inRouen, FRANCE
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical ...
based inBirmingham, ALABAMA (USA)
With Rampart, interventionalists across the nation and around the globe can finally experience comprehensive, apron-free radiation protection—all so they can do what they are passionate about and what they do best - in a safe and team oriented ...
based inChapelle-Sur-Erdre Cedex, FRANCE
Lemer Pax is a high-tech designer and manufacturer based in Nantes. As a global innovation leader in the field of radiation protection, we are a driving force for the innovative and sustainable economy in Pays de la Loire. Our top priority is to put ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based in, ARIZONA (USA)
To manage patients with advanced heart failure, every clinician will have the technology awareness and outcome data necessary to confidently consider the TAH as a therapeutic option. At SynCardia Systems, LLC, we have a very special mission: to give ...
based inMonroe Township, NEW JERSEY (USA)
We are a multinational company active in the life science sector, a world leader in imaging diagnostics. Every day we seek and perfect increasingly advanced and sustainable techniques and solutions to open new paths in diagnostic imaging. So that ...
based inBerlin, GERMANY
BIOTRONIK is a leading global medical device company with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases. Patient well-being is our top priority and has been for more than 50 ...
based inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
based inEden Prairie, MINNESOTA (USA)
ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world's first Rapid Exchange FFR and High Definition IVUS systems. It is also a global market leader in ...
CVi delivers the power to improve patient safety, minimizing the risk of contrast-induced acute kidney injury (CI-AKI) for coronary catheterizations when compared to manual injection of contrast ...
based inSunrise, FLORIDA (USA)
U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical ...
U.S. Stem Cell’s lead product candidate is MyoCell®, a muscle stem cell therapy that is intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack. The procedure ...
